Optical biomarkers for breast cancer derived from dynamic diffuse optical tomography
Molly Flexman(Columbia University), Andreas H. Hielscher(New York University), Emerson A. Lim(Columbia University), Maria Alvarez(Columbia University Irving Medical Center), Hyun Koo Kim(Korea University), Jacqueline Gunther(Columbia University), Kevin Kalinsky(Emory University), Dawn L. Hershman(Columbia University), Elise Desperito(Columbia University Irving Medical Center)
Cited by 70
Related Papers
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
|Journal of Clinical Oncology|2021|991
American Society of Clinical Oncology Position Statement on Obesity and Cancer
|Journal of Clinical Oncology|2014|524
Current Landscape of Immunotherapy in Breast Cancer
|JAMA Oncology|2019|409
AKT in cancer: new molecular insights and advances in drug development
|British Journal of Clinical Pharmacology|2016|267